KCM
VRCA icon

Kornitzer Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Kornitzer Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,425
Closed -$541K – 487
2024
Q2 		$541K Hold
7,425
– – 0.01% 430
2024
Q1 		$440K Hold
7,425
– – 0.01% 444
2023
Q4 		$544K Sell
7,425
-2,500
-25% -$103K 0.01% 429
2023
Q3 		$386K Sell
9,925
-3,000
-23% -$152K 0.01% 459
2023
Q2 		$746K Hold
12,925
– – 0.01% 425
2023
Q1 		$840K Hold
12,925
– – 0.02% 412
2022
Q4 		$355K Hold
12,925
– – 0.01% 472
2022
Q3 		$377K Hold
12,925
– – 0.01% 476
2022
Q2 		$248K Sell
12,925
-57,973
-82% -$2.91M 0.01% 497
2022
Q1 		$5.75M Hold
70,898
– – 0.09% 252
2021
Q4 		$6.49M Sell
70,898
-1,926
-3% -$218K 0.1% 253
2021
Q3 		$9.1M Hold
72,824
– – 0.14% 232
2021
Q2 		$8.23M Buy
72,824
+840
+1% +$102K 0.12% 238
2021
Q1 		$10.9M Buy
71,984
+5,433
+8% +$752K 0.17% 208
2020
Q4 		$7.66M Sell
66,551
-714
-1% -$65.6K 0.13% 232
2020
Q3 		$5.21M Buy
67,265
+18,296
+37% +$1.5M 0.1% 253
2020
Q2 		$5.39M Buy
48,969
+1,942
+4% +$225K 0.11% 243
2020
Q1 		$5.14M Buy
47,027
+2,574
+6% +$339K 0.12% 224
2019
Q4 		$7.06M Sell
44,453
-2,703
-6% -$399K 0.12% 221
2019
Q3 		$6.96M Sell
47,156
-1,134
-2% -$126K 0.13% 219
2019
Q2 		$5.61M Buy
48,290
+3,556
+8% +$334K 0.1% 240
2019
Q1 		$4.84M Buy
44,734
+11,992
+37% +$1.38M 0.09% 253
2018
Q4 		$2.67M Buy
32,742
+11,227
+52% +$1.36M 0.05% 279
2018
Q3 		$3.5M Buy
21,515
+6,791
+46% +$1.16M 0.06% 275
2018
Q2 		$2.9M Buy
+14,724
New +$2.88M 0.05% 285

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kornitzer Capital Management's VRCA Position: Q3 2024 in Review

Kornitzer Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q3 2024, closing a stake of 7,425 shares — an estimated $541K sold.

Kornitzer Capital Management first reported a position in VRCA in Q2 2018 and held it in 25 quarters. The position peaked at $10.9M in Q1 2021. 79 funds tracked by Wall St. Rank hold VRCA as of Q3 2024.

  • Kornitzer Capital Management reported no remaining Verrica Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Kornitzer Capital Management sold 7,425 Verrica Pharmaceuticals shares in Q3 2024, an estimated $541K.
  • Kornitzer Capital Management first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 25 quarters.
  • Kornitzer Capital Management's Verrica Pharmaceuticals position peaked at $10.9M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2024.

Based on Kornitzer Capital Management's 13F filing for Q3 2024, filed 31 Oct 2024.